Whole genome analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Ghana

Agbodzi, Bright; Duodu, Samuel; Dela, Helena; Kumordjie, Selassie; Yeboah, Clara; Behene, Eric; Ocansey, Karen; Yanney, Jennifer N.; Boateng-Sarfo, George; Kwofie, Samuel Kojo; Egyir, Beverly; Colston, Sophie M.; Miranda, Hugo V.; Watters, Chaselynn; Sanders, Terrel; Fox, Anne T.; Letizia, Andrew G.; Wiley, Michael R.; Attram, Naiki

doi:10.3389/fmicb.2023.1163450

Cited by 2 publications

(1 citation statement)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Ghana, and as a snapshot of the African picture, only two studies [ 15 ] and [ 16 ] have reported on the molecular characteristics of N. gonorrhoea . There are a few individual publications [ 15, 17 ] on AMR, but there is no recognized national AMR database of gonococcal isolates to inform the adopted symptomatic treatment regime.…”

Section: Introductionmentioning

confidence: 99%

Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoea isolates in Ghana

Musah,

Addy,

Dufailu

2024

Access Microbiology

View full text Add to dashboard Cite

Introduction. Gonorrhoea is a disease associated with humans and caused by Neisseria gonorrhoea. N. gonorrhoea’s ability to evolve and evade various treatment regimens can lead to untreatable gonorrhoea. In the absence of a viable vaccine and a national database on the antimicrobial resistance (AMR) and molecular characteristics of N. gonorrhoea, and with reliance on a syndromic management regime, continuous national antimicrobial resistance surveillance and molecular characterization of N. gonorrhoea remain imperative. Only two gonococcal studies have described N. gonorrhoea’s molecular characteristics linked to AMR in Ghana. Methods. Secondary N. gonorrhoea isolates (n=4) were collected from two metropolises in Ghana: Tamale in the northern sector (n=1) and Accra in the southern sector (n=3). The isolates were confirmed and characterized using polymerase chain reaction (PCR) targeting the porB and tbpB genes, and the disc diffusion method was used to evaluate AMR. N. gonorrhoea multi-antigen sequence typing (NG-MAST) and porin B (porB) gene sequence analyses were employed to reveal the molecular epidemiology and evolutionary trajectory, respectively. Results. All four isolates showed resistance to at least four of the tested antibiotics. One isolate showed resistance to all seven antibiotics, i.e. ceftriaxone, azithromycin, ciprofloxacin, tetracycline, erythromycin, togamycin and penicillin. NG-MAST typing revealed isolate S3 (MZ313864) as ST211. The locus of S2 (MZ313863) (transferrin-binding protein B; tbpB) was identified as tbpB1844, and its porB locus, as porB6412, with only 4 closely related variants but with 15 nucleotide differences. However, its sequence type does not exist. The porB analysis identified isolate S3 (MZ313864) to be found globally, while S2 (MZ313863) is unique to this study. Discussion. Despite the small number of isolates tested, this study recorded multidrug resistance and previously unknown gonococcal variants based on porB gene. Additionally, the molecular typing schemes revealed a disparity between NG-MAST and the National Center for Biotechnology Information (NCBI) platforms. There is a need for continuous gonococcal AMR and molecular surveillance in Ghana to contribute to the global efforts to describe circulating strains and support proper application of the syndromic management regime to gonorrhoea.

show abstract

Section: Introductionmentioning

confidence: 99%